| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_29ce560b2cad4652b3d77e980e87699f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2835 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2019-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f3e55dea952e273e3d08fefd9bc8d11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efc6cbfbec29bd9ecba53d993b23a8b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_177d590493536cde2e8d42cb94b086f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eed4d80f3fd5184029c986f4d58d9e43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62e483f6d9b2737a9c57d1a70d3ada1f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00f76085096e08a9e378e37947353a05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_142d1ad009ca5a2d3ab04e8aa6aa8096
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24c2a890e3b37868de1c683a623b30ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_facacfa2eca5c3a022ac8f427a91153a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f19d6616d7b70196f65ee17ec72b1464
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f48de033e57abcc2908445d193a2189
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9d03b6154cf7526017b964095e42def |
| publicationDate |
2019-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-110320367-A |
| titleOfInvention |
LAG-3-based diagnostic kit and its application in Parkinson's disease diagnostic products |
| abstract |
The invention discloses a diagnostic kit and its application in Parkinson's disease diagnostic products. The diagnostic kit includes: a specific antibody and one or more detection reagents; the specific antibody has the ability to specifically bind to the LAG-3 protein, and the detection reagent is used to cooperate with the specific antibody to detect The expression level of the LAG-3 gene in the sample. The kit uses LAG-3 protein as a biomarker for the early diagnosis of PD, which can quickly and accurately detect the level of soluble LAG-3 antibody in the subject's body fluids (such as cerebrospinal fluid and blood), which is helpful to determine the abnormal protein in the CNS The level of deposition can assist in diagnosing the risk of PD in the tested person. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114874324-A |
| priorityDate |
2019-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |